SECdecoded › JNJ
JOHNSON & JOHNSON (JNJ) insider trading
| Pinto Daniel E Director |
Grant / award size $••• · filed 2026-09-10 |
| Woods Eugene A. Director |
Grant / award size $••• · filed 2026-09-10 |
| HEWSON MARILLYN A Director |
Grant / award size $••• · filed 2026-09-10 |
| Schmid Timothy EVP, WW Chair, MedTech |
Option exercise Open-market sale size $••• · filed 2026-09-04 |
| Taubert Jennifer L EVP, WWC. Innovative Medicine |
Option exercise Open-market sale size $••• · filed 2026-08-18 |
| Duato Joaquin CEO and Chairman of the Board |
Option exercise Open-market sale size $••• · filed 2026-08-14 |
| Duato Joaquin CEO and Chairman of the Board |
Open-market sale size $••• · filed 2026-08-07 |
| Forminard Elizabeth EVP, Chief Legal Officer |
Option exercise Open-market sale size $••• · filed 2026-08-07 |
| Broadhurst Vanessa EVP, Global Corp Affairs |
Option exercise Open-market sale size $••• · filed 2026-07-21 |
| Wengel Kathryn E EVP, Chief TO and Risk Officer |
Option exercise Open-market sale size $••• · filed 2026-06-12 |
| Woods Eugene A. Director |
Grant / award size $••• · filed 2026-06-11 |
| Pinto Daniel E Director |
Grant / award size $••• · filed 2026-06-11 |
Form 4s report every insider trade. The transaction type and whether it was a pre-arranged 10b5-1 plan are shown above — the exact dollar size and what it signals are in the full analysis.
See the size of every JNJ insider trade — and whether that CEO sale was routine or a real decision — in plain English.
Open JNJ in SECdecoded → Free account · plain-English AI analysis · no card required